NCT03248115

Brief Summary

There is little information on the dietary intake, absorption, metabolism and bioavailability (degree to which a substance becomes available to the target tissues upon administration) of polyphenols (natural substances present in a variety of foods) in human participants. This study assessed the bioavailability in healthy participants of polyphenols from 2 supplements containing green tea and green coffee extracts. Eleven participants were recruited and their habitual diet was assessed to estimate polyphenol intake. After completing a 24-hour urine collection, participants were given six green tea extract and three green coffee extract tablets, which they took daily for a period of 8 weeks. No tablets were taken during the last 4 weeks of the study. Further 24-hour urines were collected at 2, 4, 8 and 12 weeks. Participants were required to attend HNR (medical laboratory) the day after each 24hour urine collection. At these visits, they were asked to bring along their urine collections, completed documents (urine collection sheet, checklist for tablet intake/side effects) and any remaining supplements, which were used to assess tablet compliance. The investigators identified and quantified the amount of polyphenols in the supplement tablets as well as the amount of polyphenols and their metabolites in urine. The investigators then evaluated polyphenol bioavailability from the relationship between their dietary intake and urinary output. Evidence from this research could inform future intervention studies by providing data on the bioavailability of green tea and coffee polyphenols, and on the individual differences related to phenolic intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 10, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2013

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

August 7, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 14, 2017

Completed
Last Updated

August 21, 2017

Status Verified

August 1, 2017

Enrollment Period

6 months

First QC Date

August 7, 2017

Last Update Submit

August 16, 2017

Conditions

Keywords

polyphenolsgreen tea catechinscoffee caffeoylquinic acidsmetabolisminter-individual variabilitycolonic microbiota

Outcome Measures

Primary Outcomes (4)

  • Change from baseline phenolic metabolites in urine at 2 weeks

    Assessment of the profile of metabolites coming from green tea and green coffee phytochemicals in urine

    Week 0 -before supplementation- and week 2

  • Change from baseline phenolic metabolites in urine at 4 weeks

    Assessment of the profile of metabolites coming from green tea and green coffee

    Week 0 -before supplementation- and week 4

  • Change from baseline phenolic metabolites in urine at 8 weeks

    Assessment of the profile of metabolites coming from green tea and green coffee

    Week 0 -before supplementation- and week 8

  • Change from baseline phenolic metabolites in urine at 12 weeks

    Assessment of the profile of metabolites coming from green tea and green coffee

    Week 0 -before supplementation- and week 12 -4 weeks after finishing the supplementation period-

Secondary Outcomes (1)

  • Phenolic compounds in tablets

    Through study completion, an average of 3 months

Interventions

1. Tablets: participants were required to take 6 green tea and 3 green coffee extract tablets daily for a period of 8 weeks. No tablets were taken during the last 4 weeks of the study. Randomly chosen tablets were analysed to quantify their polyphenol content. 2. Urine collections: Several urine collections were required during the supplementation period in order have sufficient time points to estimate the plateau of the concentration of green tea and coffee polyphenols excreted in the urine to then be able to determine their bioavailability. There was a total of five 24-hour urine collections (at week 0 -before supplementation-, 2, 4, 8, and 12 -4 weeks after finishing the supplementation period). 3. Completion of study documents: Participants were provided with urine collection sheets, polyphenol questionnaires, checklists to record polyphenol tablet intake, and detailed instructions.

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men and women.
  • years of age.
  • BMI between 18.5 and 24.9 kg/m2.

You may not qualify if:

  • Smoking.
  • Allergy or intolerance to intervention supplements.
  • Chronic, acute or active inflammatory conditions, haematological disorders, or any other systemic illness of renal, hepatic or gastrointestinal origin.
  • Major surgical operations in the gastrointestinal tract or medical treatment for gastrointestinal problems.
  • Active cancer or diagnosis of malignancy within the last five years.
  • Pregnant, lactating, contemplating pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MRC HNR Elsie Widdowson Laboratory

Cambridge, CB1 9NL, United Kingdom

Location

MeSH Terms

Interventions

Tea

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Virginia Tomatis, PhD

    MRC HNR

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 7, 2017

First Posted

August 14, 2017

Study Start

April 10, 2013

Primary Completion

October 18, 2013

Study Completion

October 18, 2013

Last Updated

August 21, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations